MAPT and dementia: Furthermore, particularly now that assessment of other brain pathologies related to dementias becomes accessible in a more direct manner through PET-CT or CSF biomarkers (for instance, amyloid-β, tau and neurofilament light), the role of CSVD in dementia might become under-appreciated due to limited markers (Table 1).